Excision Biotherapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Excision Biotherapeutics

Access the complete profile.

Excision Biotherapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	54171 Research & Development in the Physical, Engineering & Life Sciences
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	499 Jackson Street Suite 300 San Francisco, CA 94111

Note: Revenues for privately held companies are statistical evaluations.


Excision Biotherapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Excision Biotherapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Excision Biotherapeutics is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.

Excision Biotherapeutics Annual Revenue and Growth Rate

Excision Biotherapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Excision Biotherapeutics's revenues are gauged from an analysis of company filings.

Excision Biotherapeutics's Income Statement (based on Industry Averages)

Excision Biotherapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Excision Biotherapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 3, 2021	0	N/A	$0 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of Excision Biotherapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Excision Biotherapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
AXIOM SPACE	Houston, TX	1
ADVANCED CLINICAL HOLDINGS	Deerfield, IL	1
PONCE MEDICAL SCHOOL FOUNDATION	Ponce, PR	1
MARSHALL UNIVERSITY	Huntington, WV	1
RESEARCH INNOVATIONS	Alexandria, VA	1
VOYAGER SPACE HOLDINGS	Denver, CO	1
DEEP NORTH	Redwood City, CA	0
EPIRUS	Hawthorne, CA	0

Nearby Competitors

These companies are similar in business line and location to Excision Biotherapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
OPENAI	San Francisco, CA	100
J.DAVID GLADSTONE INSTITUTES	San Francisco, CA	73
FIRSTLAYERAI	San Francisco, CA	67
EMBARK TRUCKS	San Francisco, CA	65
IDEO	San Francisco, CA	60
NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH & EDUCATION	San Francisco, CA	37

Other Companies at 499 Jackson Street, San Francisco CA

Company	Headquarters	Revenue ($ MM)
LOVEFROM	San Francisco, CA	100
GREATPOINT INVESTMENT MANAGEMENT	San Francisco, CA	62
ARTIS VENTURES MANAGEMENT	San Francisco, CA	43

Future Competition: Excision Biotherapeutics's Fastest Growing Competitors

These companies are in the same general field as Excision Biotherapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)